This Article Full Text Full Text (PDF) All Versions of this Article: 33/12/2756    most recent 01.STR.0000039322.66575.77v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Prager, M. Articles by Wojta, J. Search for Related Content PubMed PubMed Citation Articles by Prager, M. Articles by Wojta, J. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Carotid Artery Disease Related Collections Pathophysiology Risk Factors Other Stroke

(Stroke. 2002;33:2756.)
© 2002 American Heart Association, Inc.

Original Contributions

Chlamydia pneumoniae in Carotid Artery Atherosclerosis

A Comparison of Its Presence in Atherosclerotic Plaque, Healthy Vessels, and Circulating Leukocytes From the Same Individuals

Manfred Prager, MD; Zeynep Türel, BSc; Walter S. Speidl, MD; Gerlinde Zorn, BSc; Christoph Kaun, BSc; Alexander Niessner, MD; Georg Heinze, PhD; Igor Huk, MD; Gerald Maurer, MD; Kurt Huber, MD Johann Wojta, PhD

From the Departments of Vascular Surgery (M.P., I.H.), Internal Medicine II (Z.T., W.S.S., G.Z., C.K., A.N., G.M., K.H., J.W.), and Medical Computer Sciences (G.H.), University of Vienna, Vienna, Austria.

Correspondence to Johann Wojta, Department of Internal Medicine II, University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria. E-mail johann.wojta{at}univie.ac.at

Background and Purpose— There is growing clinical and experimental evidence that infections with Chlamydia pneumoniae might contribute to the development and progression of atherosclerosis. However, studies detecting the pathogen in atherosclerotic lesions examined either only atherosclerotic vessels or control vessels without atherosclerosis obtained from a different group of individuals. We analyzed atherosclerotic plaques of the carotid artery, samples of apparently healthy greater saphenous veins, and circulating leukocytes from the same individual patients for the presence of C pneumoniae.

Methods— From each of 46 patients undergoing carotid endarterectomy for symptomatic carotid artery stenosis, these samples were analyzed by nested polymerase chain reaction for C pneumoniae–specific DNA. Furthermore, we determined IgA and IgG titers specific for the pathogen and plasma levels of C-reactive protein in these patients.

Results— C pneumoniae DNA was detected in 86.9% of the leukocytes and in 82.6% of the atherosclerotic plaques but in only 6.5% of the saphenous veins. In 85% of patients who also had leukocytes positive for C pneumoniae, the atherosclerotic plaques were positive and the saphenous veins were negative. The presence of C pneumoniae–specific DNA in leukocytes significantly coincided with the presence of the respective DNA in the plaques of the carotid arteries (P=0.0002). No association between the presence of C pneumoniae and specific IgA or IgG levels was seen. C-reactive protein levels were significantly higher in patients with chlamydia-positive atherosclerotic plaques and with positive leukocytes than in patients with negative plaques of the carotid arteries or negative leukocytes, respectively (P<0.01, P<0.05).

Conclusions— Our observation of >80% incidence of C pneumoniae in atherosclerotic plaques of the carotid artery does not prove causality between an infection with the pathogen and the development of atherosclerosis. It must be emphasized, however, that >90% of apparently healthy saphenous veins were negative for C pneumoniae. Given the structural and functional differences between veins and arteries, careful interpretation of our results regarding a possible causative role of C pneumoniae seems warranted.

Key Words: atherosclerosis • bacteria • coronary vessels • leukocytes

This article has been cited by other articles:

				T W Weiss, H Kvakan, C Kaun, M Prager, W S Speidl, G Zorn, S Pfaffenberger, I Huk, G Maurer, K Huber, et al. No evidence for a direct role of Helicobacter pylori and Mycoplasma pneumoniae in carotid artery atherosclerosis J. Clin. Pathol., November 1, 2006; 59(11): 1186 - 1190. [Abstract] [Full Text] [PDF]

				P. Apfalter, W. Barousch, M. Nehr, B. Willinger, M. Rotter, and A. M. Hirschl No Evidence of Involvement of Chlamydia pneumoniae in Severe Cerebrovascular Atherosclerosis by Means of Quantitative Real-Time Polymerase Chain Reaction Stroke, September 1, 2004; 35(9): 2024 - 2028. [Abstract] [Full Text] [PDF]

				V. Y. Hoymans, J. M. Bosmans, D. Ursi, W. Martinet, F. L. Wuyts, E. Van Marck, M. Altwegg, C. J. Vrints, and M. M. Ieven Immunohistostaining Assays for Detection of Chlamydia pneumoniae in Atherosclerotic Arteries Indicate Cross-Reactions with Nonchlamydial Plaque Constituents J. Clin. Microbiol., July 1, 2004; 42(7): 3219 - 3224. [Abstract] [Full Text] [PDF]

				P. Apfalter, M. R. Hammerschlag, J. Boman, J. Wojta, K. Huber, and I. Huk Reliability of Nested PCR for the Detection of Chlamydia pneumoniae in Carotid Artery Atherosclerosis Stroke, July 1, 2003; 34 (7): e73 - e75. [Full Text] [PDF]